This story is adapted from Slate’s new and revamped Slatest newsletter. You can sign up here to get it in your inbox every day.

The presidency comes with certain perks: a taxpayer-funded plane, a lifetime pension, and a White House staff to service the commander in chief’s every need. But for Donald Trump, another benefit may be early access to what could be the world’s most effective weight loss medication. Today we’re breaking down the story that has everyone speculating.

Back up. What in the world are you talking about? 

The medical news site STAT reported this morning that the Food and Drug Administration and the drugmaker Eli Lilly recently granted a 79-year-old man access to an experimental anti-obesity drug called retatrutide. (If you can pronounce that, you win a prize.) The anonymous man applied for retatrutide in April through the FDA’s “compassionate use” program, which lets seriously ill patients access treatments that are still in development. A top National Institutes of Health clinician made the request, which suggests the patient is politically well connected.

A politically connected man who was 79 in April? That … sounds a lot like the president.

It does! Trump, who just turned 80, fits the profile. He’s also obsessed with........

© Slate